Chugai Pharma Usa LLC is categorized under Medical Research in Berkeley Heights, NJ and active since 1995.
Chugai Pharma Usa LLC was established in 1995, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact Kazutaka Okada at the company’s single location by writing to 300 Connell Drive # 3100, Berkeley Heights, New Jersey NJ 07922 or by phoning (908) 516-1350. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Chugai Pharma Usa LLC |
| Contact Person: | Kazutaka Okada |
| Address: | 300 Connell Drive # 3100, Berkeley Heights, New Jersey 07922 |
| Phone Number: | (908) 516-1350 |
| Website Address: | chugai-pharm.com |
| Annual Revenue (USD): | $5.000.000 to $9.999.999 |
| Founded: | 1995 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 541720 |
| Share This Business: |
Chugai Pharma Usa LLC was started in 1995 to provide professional Medical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact Kazutaka Okada for inquiries that concern Chugai Pharma Usa LLC by calling the company number (908) 516-1350, as your correspondence is most welcome. Additionally, the physical location of the single location of Chugai Pharma Usa LLC can be found at the coordinates 40.661504,-74.416765 as well as the street address 300 Connell Drive # 3100 in Berkeley Heights, New Jersey 07922.
For its online presence, you may visit Chugai Pharma Usa LLC’s website at chugai-pharm.com and engage with its social media outlets through on Twitter and on Facebook.